Elevated liver enzymes at the time of deceased donor organ donation do not affect recipient or pancreas allograft survival following pancreas transplantation
HPB · 2024
DOI: 10.1016/j.hpb.2024.04.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2024. Verfasst von Evan M Sood und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jacobs School of Medicine and Biomedical Sciences at University at Buffalo, 955 Main St, Buffalo, NY, 14203, USA. Hauptthemen laut MEDLINE: Pancreas Transplantation, Graft Survival, Bilirubin, Liver Function Tests. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: There is a lack of data on the impact of donor liver function tests (LFTs) on pancreas transplantation outcomes. Understanding their contribution could expand the donor pool. METHODS: Using the UNOS database, data from January 2010-2022 was retrospectively analyzed. Multivariable cox regressions were performed to evaluate the association between LFTs (AST, ALT and total bilirubin levels), graft failure and mortality up to three years post-transplant. RESULTS: 9138 pancreas transplants were completed. Multivariate analysis showed no association between donor AST values > 500 U/L and increased rates of graft failure (p = 0.826) or mortality (p = 0.836). Similar findings were noted for donor ALT values > 500 U/L (p = 0.522 and p = 0.997, respectively). There was no correlation with graft failure (p = 0.322) or mortality (p = 0.423) for total bilirubin levels >3 mg/dL. CONCLUSION: LFTs in the deceased pancreas donor did not increase risk of graft failure or mortality following pancreas transplantation. Elevated LFTs should not serve as absolute contraindications to transplant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jacobs School of Medicine and Biomedical Sciences at University at Buffalo, 955 Main St, Buffalo, NY, 14203, USA.
- George Mason University, 4400 University Dr, Fairfax, VA, 22030, USA.
- Department of Surgery, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA.
- Department of Surgery, Erie County Medical Center, 462 Grider St, Buffalo, NY, 14215, USA. Electronic address: jortiz22@buffalo.edu.
Zitieren
APA
Sood, E. M., Bomfim, F., Delmonte, A., DeSantis, K., James, R., Koizumi, N., Plews, R., & Ortiz, J. (2024). Elevated liver enzymes at the time of deceased donor organ donation do not affect recipient or pancreas allograft survival following pancreas transplantation. HPB. https://doi.org/10.1016/j.hpb.2024.04.012
Vancouver
Sood EM, Bomfim F, Delmonte A, DeSantis K, James R, Koizumi N, et al. Elevated liver enzymes at the time of deceased donor organ donation do not affect recipient or pancreas allograft survival following pancreas transplantation. HPB. 2024. doi:10.1016/j.hpb.2024.04.012
BibTeX
@article{Sood2024,
author = {Sood, Evan M and Bomfim, Fernando and Delmonte, Abbigail and DeSantis, Kendall and James, Rosy and Koizumi, Naoru and Plews, Robert and Ortiz, Jorge},
title = {Elevated liver enzymes at the time of deceased donor organ donation do not affect recipient or pancreas allograft survival following pancreas transplantation},
journal = {HPB},
year = {2024},
doi = {10.1016/j.hpb.2024.04.012}
}
EUVIMED